A detailed history of Jb Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jb Capital LLC holds 95,340 shares of MRK stock, worth $9.54 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
95,340
Previous 92,105 3.51%
Holding current value
$9.54 Million
Previous $11.4 Million 5.05%
% of portfolio
0.63%
Previous 0.72%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $359,570 - $417,217
3,235 Added 3.51%
95,340 $10.8 Million
Q2 2024

Jul 24, 2024

BUY
$123.8 - $132.96 $278,302 - $298,894
2,248 Added 2.5%
92,105 $11.4 Million
Q1 2024

Apr 30, 2024

BUY
$113.24 - $131.95 $91,044 - $106,087
804 Added 0.9%
89,857 $11.9 Million
Q4 2023

Jan 22, 2024

BUY
$100.18 - $109.02 $1.27 Million - $1.39 Million
12,716 Added 16.66%
89,053 $9.71 Million
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $1.08 Million - $1.2 Million
10,484 Added 15.92%
76,337 $7.86 Million
Q2 2023

Jul 25, 2023

BUY
$108.61 - $118.38 $170,300 - $185,619
1,568 Added 2.44%
65,853 $7.6 Million
Q1 2023

Apr 25, 2023

BUY
$102.94 - $114.86 $39,734 - $44,335
386 Added 0.6%
64,285 $6.84 Million
Q4 2022

Jan 23, 2023

BUY
$87.44 - $112.11 $148,997 - $191,035
1,704 Added 2.74%
63,899 $0
Q3 2022

Oct 14, 2022

BUY
$84.53 - $94.96 $3.93 Million - $4.41 Million
46,445 Added 294.89%
62,195 $5.36 Million
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $91,421 - $103,630
1,095 Added 7.47%
15,750 $1.44 Million
Q1 2022

Apr 19, 2022

BUY
$73.51 - $82.4 $88,138 - $98,797
1,199 Added 8.91%
14,655 $1.2 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $706,970 - $885,571
9,781 Added 266.15%
13,456 $1.03 Million
Q3 2021

Dec 08, 2021

BUY
$71.68 - $78.83 $263,424 - $289,700
3,675 New
3,675 $276,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Jb Capital LLC Portfolio

Follow Jb Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.